Region’s first patient receives sickle cell gene therapy
WashU Medicine and St. Louis Children’s Hospital are the first in the region — and among only a few academic centers in the U.S. — to begin offering a newly approved gene therapy to cure sickle cell disease. Martin Mwita Jr. (right) traveled with his mother from their home in Nebraska to St. Louis to receive the innovative treatment.